| Identification | Back Directory | [Name]
sulfo-SPDB-DM4 | [CAS]
1626359-59-8 | [Synonyms]
sulfo-SPDB-DM4
Maytansine, N2'-deacetyl-N2'-[4-[[4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-4-oxo-3-sulfobutyl]dithio]-4-methyl-1-oxopentyl]-
4-((5-(((S)-1-(((14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl)oxy)-1-oxopropan-2-yl)(methyl)amino)-2-methyl-5-oxopentan-2-yl)disulfanyl)-1-((2,5-dioxopyrrolidin-1-yl)oxy)-1-oxobutane-2-sulfonic acid | [Molecular Formula]
C46H63ClN4O17S3 | [MDL Number]
MFCD30378973 | [MOL File]
1626359-59-8.mol | [Molecular Weight]
1075.66 |
| Hazard Information | Back Directory | [Uses]
sulfo-SPDB-DM4 is a agent-linker conjugate for ADC by using the maytansinebased payload (DM4, an antitubulin agent) via the sulfo-SPDB linker. | [IC 50]
Maytansinoids | [References]
[1] Tang R, et al. P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patients. BMC Cancer. 2009 Jun 23;9:199. DOI:10.1186/1471-2407-9-199 |
|
| Company Name: |
Twochem Co.Ltd
|
| Tel: |
021-021-58111628 15800915896 |
| Website: |
www.twochem.com |
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
|